In as little as 2 years, patients with type 2 diabetes may exhibit diminished global and regional cerebral vasoreactivity, which could negatively affect cognitive skills, a small study suggests. The findings were published online July 8 in Neurology.
Higher levels of dopamine may increase risk-taking behaviors in healthy people, much like dopamine-boosting medications have been shown to do in people with Parkinson's disease, according to research published in the July 8 issue of the Journal of Neuroscience.
An IGF2 variant (c.191C→A, p.Ser64Ter) affects postnatal as well as prenatal growth among those who have inherited the variant through paternal transmission, according to a report published online July 8 in the New England Journal of Medicine.
The panelists discuss vitamin D levels and multiple sclerosis risk, noting that there is some evidence suggesting vitamin D level has some impact on disease severity in multiple sclerosis. They also briefly discuss the gut microbiome and the potential role played by intestinal flora in disease risk.